Flexion's non-opioid pain management drug has huge potential, and it's looking to expand into more indications.
Don't be one of them!
Two years ago we tossed out a terrible ballpark on the revenue Apple Music might be able to bring in for the tech giant. Today we talk about that mistake and how to set yourself up to make better projections.
Shopify and its founder, Tobias Lutke, have been Fool favorites for a long time. On this episode we talk about why, despite the stock's crazy run over the past year, we'd still buy shares of this e-commerce company.
What looks on the surface like a terrible decision may actually have been my best in 2017.
Everyone makes mistakes, but these could be particularly painful.
When a company is sitting on that much money, it's worth speculating on how the company could use it.
Some IPOs, especially tech ones, balloon up to three times their valuation on opening day, but investors would be wise to wait a few quarters before diving in.
Growth? Check. Dividend? Check. Diversification? Check. And there are seven more.
The average investor has a wealth of information at their fingertips -- they just need to know where to find it.
Less is more.
Real estate, dividends, and growth can make for a powerful combination.
Motley Fool analyst Michael Douglass joins host Gaby Lapera to discuss key takeaways from this year's Berkshire Hathaway annual meeting.
Warren Buffett claims the biggest issue facing American businesses as they compete abroad is healthcare, not taxes.
Unsurprisingly, they love him. But here's what we can learn from that.
Unsure what to do at this special time in Omaha? We've got you covered.
A big dividend raise isn't always the right move for a business.
This is one of the most-asked credit card questions.
These credit essentials could help build your credit score faster.